{"pmid":32380821,"title":"Using therapeutic plasma exchange as a rescue therapy in CoVID-19 patients: a case series.","text":["Using therapeutic plasma exchange as a rescue therapy in CoVID-19 patients: a case series.","Pol Arch Intern Med","Adeli, Seyed Hasan","Asghari, Akram","Tabarraii, Reihane","Shajari, Rasoul","Afshari, Sara","Kalhor, Narges","Vafaeimanesh, Jamshid","32380821"],"journal":"Pol Arch Intern Med","authors":["Adeli, Seyed Hasan","Asghari, Akram","Tabarraii, Reihane","Shajari, Rasoul","Afshari, Sara","Kalhor, Narges","Vafaeimanesh, Jamshid"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32380821","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.20452/pamw.15340","topics":["Case Report"],"weight":1,"_version_":1666419683306242048,"score":9.490897,"similar":[{"pmid":32298745,"pmcid":"PMC7194512","title":"Successful treatment of plasma exchange followed by intravenous immunogloblin in a critically ill patient with 2019 novel coronavirus infection.","text":["Successful treatment of plasma exchange followed by intravenous immunogloblin in a critically ill patient with 2019 novel coronavirus infection.","We report a case of a laboratory-confirmed 2019 novel coronavirus infected (known as COVID-19) patient who developed respiratory failure and shock accompanied by persistent diarrhoea despite conventional therapeutic interventions. The patient avoided mechanical ventilation and acquired an immediate clinical and radiological improvement, after treatment of intensive plasma exchange (PE) followed by intravenous immunogloblin (IVIG). Successful therapeutic strategies in our case suggest timely initiating PE treatment followed by IVIG in critically ill patients with COVID-19 may prevent the disease from worsening and help to reduce the requirements for mechanical ventilation and intensive supportive care. What's more, it may improve poor clinical outcomes of these patients.","Int J Antimicrob Agents","Shi, Hua","Zhou, Chaomin","He, Pinghong","Huang, Sheng","Duan, Youjun","Wang, Xuesheng","Lin, Kexiong","Zhou, Chao","Zhang, Xiangyan","Zha, Yan","32298745"],"abstract":["We report a case of a laboratory-confirmed 2019 novel coronavirus infected (known as COVID-19) patient who developed respiratory failure and shock accompanied by persistent diarrhoea despite conventional therapeutic interventions. The patient avoided mechanical ventilation and acquired an immediate clinical and radiological improvement, after treatment of intensive plasma exchange (PE) followed by intravenous immunogloblin (IVIG). Successful therapeutic strategies in our case suggest timely initiating PE treatment followed by IVIG in critically ill patients with COVID-19 may prevent the disease from worsening and help to reduce the requirements for mechanical ventilation and intensive supportive care. What's more, it may improve poor clinical outcomes of these patients."],"journal":"Int J Antimicrob Agents","authors":["Shi, Hua","Zhou, Chaomin","He, Pinghong","Huang, Sheng","Duan, Youjun","Wang, Xuesheng","Lin, Kexiong","Zhou, Chao","Zhang, Xiangyan","Zha, Yan"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32298745","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.ijantimicag.2020.105974","keywords":["diarrhoea","immunogloblin","novel coronavirus","plasma exchange"],"locations":["immunogloblin","immunogloblin"],"topics":["Case Report"],"weight":1,"_version_":1666138493231824898,"score":45.558678},{"pmid":32427773,"title":"Rescue Therapy for Severe COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) with Tissue Plasminogen Activator (tPA): A Case Series.","text":["Rescue Therapy for Severe COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) with Tissue Plasminogen Activator (tPA): A Case Series.","The COVID-19 pandemic has led to unprecedented stresses on modern medical systems, overwhelming the resource infrastructure in numerous countries while presenting a unique series of pathophysiologic clinical findings. Thrombotic coagulopathy is common in critically ill patients suffering from COVID-19, with associated high rates of respiratory failure requiring prolonged periods of mechanical ventilation. Here we report a case series of five patients suffering from profound, medically refractory COVID-19 associated respiratory failure who were treated with fibrinolytic therapy using tissue plasminogen activator (tPA, Alteplase). All five patients appeared to have an improved respiratory status following tPA administration: one patient had an initial marked improvement that partially regressed after several hours, one patient had transient improvements that were not sustained, and three patients had sustained clinical improvements following tPA administration.","J Trauma Acute Care Surg","Barrett, Christopher D","Oren-Grinberg, Achikem","Chao, Edward","Moraco, Andrew H","Martin, Matthew J","Reddy, Srinivas H","Ilg, Annette M","Jhunjhunwala, Rashi","Uribe, Marco","Moore, Hunter B","Moore, Ernest E","Baedorf-Kassis, Elias N","Krajewski, Megan L","Talmor, Daniel S","Shaefi, Shahzad","Yaffe, Michael B","32427773"],"abstract":["The COVID-19 pandemic has led to unprecedented stresses on modern medical systems, overwhelming the resource infrastructure in numerous countries while presenting a unique series of pathophysiologic clinical findings. Thrombotic coagulopathy is common in critically ill patients suffering from COVID-19, with associated high rates of respiratory failure requiring prolonged periods of mechanical ventilation. Here we report a case series of five patients suffering from profound, medically refractory COVID-19 associated respiratory failure who were treated with fibrinolytic therapy using tissue plasminogen activator (tPA, Alteplase). All five patients appeared to have an improved respiratory status following tPA administration: one patient had an initial marked improvement that partially regressed after several hours, one patient had transient improvements that were not sustained, and three patients had sustained clinical improvements following tPA administration."],"journal":"J Trauma Acute Care Surg","authors":["Barrett, Christopher D","Oren-Grinberg, Achikem","Chao, Edward","Moraco, Andrew H","Martin, Matthew J","Reddy, Srinivas H","Ilg, Annette M","Jhunjhunwala, Rashi","Uribe, Marco","Moore, Hunter B","Moore, Ernest E","Baedorf-Kassis, Elias N","Krajewski, Megan L","Talmor, Daniel S","Shaefi, Shahzad","Yaffe, Michael B"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32427773","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1097/TA.0000000000002786","topics":["Case Report"],"weight":1,"_version_":1667252837920276480,"score":45.01272},{"pmid":32453903,"title":"Efficacy of therapeutic plasma exchange in severe COVID-19 patients.","text":["Efficacy of therapeutic plasma exchange in severe COVID-19 patients.","Coronavirus disease 2019 (COVID-19) could lead to a sharp increase in the levels of inflammatory cytokines. We report the efficacy of therapeutic plasma exchange in severe COVID-19 patients with acute respiratory distress syndrome. The results suggested TPE could be used as a strategy to attenuate circulating cytokines and inflammatory mediators.","Br J Haematol","Zhang, Li","Zhai, Hui","Ma, Shasha","Chen, Jiasheng","Gao, Yu","32453903"],"abstract":["Coronavirus disease 2019 (COVID-19) could lead to a sharp increase in the levels of inflammatory cytokines. We report the efficacy of therapeutic plasma exchange in severe COVID-19 patients with acute respiratory distress syndrome. The results suggested TPE could be used as a strategy to attenuate circulating cytokines and inflammatory mediators."],"journal":"Br J Haematol","authors":["Zhang, Li","Zhai, Hui","Ma, Shasha","Chen, Jiasheng","Gao, Yu"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32453903","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/bjh.16890","keywords":["coronavirus disease 2019 (covid-19)","cytokine storm","inflammatory parameters","oxygenation parameters","therapeutic plasma exchange"],"topics":["Treatment"],"weight":1,"_version_":1667881798356434944,"score":43.739883},{"pmid":32359878,"title":"Application of plasma exchange in association with higher dose CVVH in Cytokine Storm Complicating COVID-19.","text":["Application of plasma exchange in association with higher dose CVVH in Cytokine Storm Complicating COVID-19.","J Formos Med Assoc","Lin, Jui-Hsiang","Chen, Yu-Cheng","Lu, Chien-Lu","Hsu, Yuan-Nian","Wang, Wei-Jie","32359878"],"journal":"J Formos Med Assoc","authors":["Lin, Jui-Hsiang","Chen, Yu-Cheng","Lu, Chien-Lu","Hsu, Yuan-Nian","Wang, Wei-Jie"],"date":"2020-05-04T11:00:00Z","year":2020,"_id":"32359878","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.jfma.2020.04.023","topics":["Case Report"],"weight":1,"_version_":1666138495900450816,"score":41.70611},{"pmid":32398378,"title":"Get rid of the bad first: Therapeutic plasma exchange with convalescent plasma for severe COVID-19.","text":["Get rid of the bad first: Therapeutic plasma exchange with convalescent plasma for severe COVID-19.","Proc Natl Acad Sci U S A","Kesici, Selman","Yavuz, Sinan","Bayrakci, Benan","32398378"],"journal":"Proc Natl Acad Sci U S A","authors":["Kesici, Selman","Yavuz, Sinan","Bayrakci, Benan"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32398378","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1073/pnas.2006691117","topics":["Treatment"],"weight":1,"_version_":1666714494890409984,"score":40.838192}]}